<DOC>
	<DOCNO>NCT02608528</DOCNO>
	<brief_summary>Evaluation FDG PET/CT image immunotherapy response adult thoracic cancer . Compare pre- post-treatment primary tumor uptake FDG-PET/CT correlate clinical marker response . PET/CT tumor metabolic response also correlate progression-free survival overall survival .</brief_summary>
	<brief_title>Serial 18FFluorodeoxyglucose ( 18FFDG ) PET/CT Biomarker Therapeutic Response Anti-PD1/PDL1 Therapy</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Adult patient , least 18 year age Histologically confirm nonsmall cell lung cancer malignancy pleural mesothelioma least one site disease &gt; 1 cm least one type standard imaging ( e.g . CT , chest xray , MRI ) Recommended start antiPD1/PDL1 therapy . Obtaining prePD1/PDL1 therapy clinical restaging [ 18F ] FDGPET/CT scan Hospital University Pennsylvania . Participants must inform investigational nature study provide write informed consent accordance institutional federal guideline prior studyspecific procedure . Participants must willing able comply schedule visit image procedure opinion investigator treat physician . Exclusion Criteria Females pregnant breastfeeding time screen eligible study . Female participant childbearing potential urine pregnancy test time screen visit . Patients single site primary nonsmall cell lung cancer malignancy pleural mesothelioma undergone recommend undergo radiation therapy site eligible , inclusion patient may undergo radiation therapy ancillary disease site may allow enter study discretion PI felt affect ability capture [ 18F ] FDG information least one primary site disease . Patients undergone cancer surgery remove significant portion active disease , opinion investigator , within 2 month prior study enrollment exclude . Patients receive prior immunotherapy . Patients active autoimmune disease ( ie . Multiple sclerosis , rheumatoid arthritis , systemic lupus erythematosus , vasculitis ) . Inability tolerate image procedure opinion investigator treat physician Serious unstable medical psychological condition , opinion investigator would compromise subject 's safety successful participation study . Unwilling unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>